Elbein A D, Dorling P R, Vosbeck K, Horisberger M
J Biol Chem. 1982 Feb 25;257(4):1573-6.
Swainsonine, an indolizidine alkaloid, inhibits the alpha-mannosidase that is involved in glycoprotein processing. Thus, in cultured animal cells, this alkaloid causes an increase in the surface content of high mannose glycoproteins and a decrease in the amount of complex type glycoproteins (Elbein, A. D., Solf, R., Dorling, P. R., and Vosbeck, K. (1982) Proc. Natl. Acad. Sci. U. S. A., 78, 7393-7397). In this report, the effect of swainsonine on the synthesis virus hemagglutinins was examined. Primary calf kidney cultures were infected with influenza virus and viral replication was allowed to proceed in the absence or presence of swainsonine. Several hours after the addition of swainsonine, [2-3H]mannose or [6-3H]glucosamine were added to label the hemagglutinins and the mature virus particles were isolated. Virus particles raised in the presence of this alkaloid had the same infectivity and hemagglutination titer as virus particles from control cells. However, when the hemagglutinins were examined on sodium dodecyl sulfate gels, the major hemagglutinin (HA0) and its subunits, HA1 and HA2, from swainsonine-treated cells, migrated faster, indicating that they were of lower molecular weights. The labeled hemagglutinins were digested with pronase and the resulting glycopeptides were chromatographed on Bio-Gel P-4. Both the mannose-labeled and glucosamine-labeled glycopeptides from swainsonine-treated virus migrated more slowly on these columns than those of controls cells, suggesting that they were altered in structure. Furthermore, when the glycopeptides were digested with endoglucosaminidase H, 90% of the glycopeptides from swainsonine-treated cells were susceptible to this enzyme, whereas only 30% of those from control cells were digested. The major oligosaccharide released from inhibited cells by endoglucosaminidase H was digestible with alpha-mannosidase, whereas that of control cells was resistant to this enzyme. However, the control cell glycopeptide was digested by a combination of neuraminidase, beta-galactosidase, beta-N-acetylhexosaminidase, and alpha-mannosidase. These data show that swainsonine prevents the formation of complex glycoproteins and gives rise to increased amounts of high-mannose glycoproteins.
苦马豆素是一种吲哚里西啶生物碱,可抑制参与糖蛋白加工的α-甘露糖苷酶。因此,在培养的动物细胞中,这种生物碱会导致高甘露糖糖蛋白的表面含量增加,而复合型糖蛋白的含量减少(埃尔宾,A. D.,索尔夫,R.,多林,P. R.,和沃斯贝克,K.(1982年)《美国国家科学院院刊》,78,7393 - 7397)。在本报告中,研究了苦马豆素对病毒血凝素合成的影响。用流感病毒感染原代小牛肾培养物,并在有或没有苦马豆素的情况下让病毒复制进行。加入苦马豆素数小时后,加入[2 - ³H]甘露糖或[6 - ³H]葡糖胺以标记血凝素,并分离出成熟的病毒颗粒。在这种生物碱存在下产生的病毒颗粒与对照细胞的病毒颗粒具有相同的感染力和血凝滴度。然而,当在十二烷基硫酸钠凝胶上检测血凝素时,来自苦马豆素处理细胞的主要血凝素(HA0)及其亚基HA1和HA2迁移得更快,表明它们的分子量较低。用链霉蛋白酶消化标记的血凝素,所得糖肽在Bio - Gel P - 4上进行色谱分析。来自苦马豆素处理病毒的甘露糖标记和葡糖胺标记的糖肽在这些柱上的迁移速度比对照细胞的糖肽慢,这表明它们的结构发生了改变。此外,当用内切葡糖胺酶H消化糖肽时,来自苦马豆素处理细胞的糖肽中有90%对该酶敏感,而来自对照细胞的糖肽只有30%被消化。内切葡糖胺酶H从受抑制细胞中释放的主要寡糖可被α-甘露糖苷酶消化,而对照细胞的寡糖对此酶有抗性。然而,对照细胞的糖肽可被神经氨酸酶、β-半乳糖苷酶、β-N-乙酰己糖胺酶和α-甘露糖苷酶联合消化。这些数据表明,苦马豆素可阻止复合型糖蛋白的形成,并导致高甘露糖糖蛋白的量增加。